AU2003205174A1 - Molecules for disease detection and treatment - Google Patents

Molecules for disease detection and treatment

Info

Publication number
AU2003205174A1
AU2003205174A1 AU2003205174A AU2003205174A AU2003205174A1 AU 2003205174 A1 AU2003205174 A1 AU 2003205174A1 AU 2003205174 A AU2003205174 A AU 2003205174A AU 2003205174 A AU2003205174 A AU 2003205174A AU 2003205174 A1 AU2003205174 A1 AU 2003205174A1
Authority
AU
Australia
Prior art keywords
molecules
treatment
disease detection
disease
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003205174A
Other languages
English (en)
Inventor
Stefan R. Amshey
Alice J. Chen
Joyce Chinn
Christopher R. Dahl
Tam C. Dam
Gerard E. Dufour
Edward H. Gerstin Jr.
Darryl Gietzen
Jennifer L. Jackson
Anissa L. Jones
Vijaykumar Kolluru
Sreenivasa R. Kristnam
Ruth Y. Lan
Samantha A. Lewis
Tommy F. Liu
Rakesh Marwaha
Iqbal S. Panesar
Careyna H. Peralta
Olivia Tuason
Michael E. Urashka
Pierre E. Yap
Jimmy Y. Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2003205174A1 publication Critical patent/AU2003205174A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003205174A 2002-01-17 2003-01-14 Molecules for disease detection and treatment Abandoned AU2003205174A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34994602P 2002-01-17 2002-01-17
US34941302P 2002-01-17 2002-01-17
US60/349,413 2002-01-17
US60/349,946 2002-01-17
PCT/US2003/001363 WO2003062379A2 (fr) 2002-01-17 2003-01-14 Molecules pour la detection et le traitement de maladies

Publications (1)

Publication Number Publication Date
AU2003205174A1 true AU2003205174A1 (en) 2003-09-02

Family

ID=27616740

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003205174A Abandoned AU2003205174A1 (en) 2002-01-17 2003-01-14 Molecules for disease detection and treatment
AU2003236612A Abandoned AU2003236612A1 (en) 2002-01-17 2003-01-15 Secretory molecules

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003236612A Abandoned AU2003236612A1 (en) 2002-01-17 2003-01-15 Secretory molecules

Country Status (2)

Country Link
AU (2) AU2003205174A1 (fr)
WO (2) WO2003062379A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003336A2 (fr) * 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Choline-phosphotransferases et ethanolamine-phosphotransferases nouvellement identifiees
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
AU2011305655B2 (en) 2010-09-22 2015-11-05 Alios Biopharma, Inc. Substituted nucleotide analogs
EP2794630A4 (fr) 2011-12-22 2015-04-01 Alios Biopharma Inc Analogues de nucléotide phosphorothioate substitués
WO2013142124A1 (fr) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Formes solides d'un promédicament nucléotidique thiophosphoramidate
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US6277977B1 (en) * 1997-06-11 2001-08-21 Smithkline Beecham Corporation cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor
CA2296792A1 (fr) * 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
WO2001053312A1 (fr) * 1999-12-23 2001-07-26 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides

Also Published As

Publication number Publication date
WO2003062385A2 (fr) 2003-07-31
AU2003236612A8 (en) 2006-11-09
WO2003062385A3 (fr) 2006-09-08
WO2003062379A2 (fr) 2003-07-31
AU2003236612A1 (en) 2003-09-02
WO2003062379A3 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2002338265A1 (en) Molecules for disease detection and treatment
AU2003232485A1 (en) Neopeptides and methods useful for detection and treatment of cancer
EP1552002A4 (fr) Molecules toxine-aptamere et procedes d'utilisation correspondants
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002329784A1 (en) Molecules for disease detection and treatment
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002364890A1 (en) Molecules for disease detection and treatment
AU2003205174A1 (en) Molecules for disease detection and treatment
AU2003268023A1 (en) Protein modification and maintenance molecules
AU2003205353A1 (en) Protein modification and maintenance molecules
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2002243539A1 (en) Molecules for disease detection and treatment
AU2002347899A1 (en) Molecules for disease detection and treatment
AU2003231245A1 (en) Molecules for disease detection and treatment
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2002359567A1 (en) Molecules for disease detection and treatment
AU2002248723A1 (en) Molecules for disease detection and treatment
AU2002239543A1 (en) Molecules for disease detection and treatment
AU2003239871A1 (en) Protein modification and maintenance molecules
AU5319400A (en) Molecules for disease detection and treatment
AU2002320026A1 (en) Molecules for disease detection and treatment
EP1390410A4 (fr) Molecules de detection et de traitement de maladies
AU2003231981A1 (en) Protein modification and maintenance molecules
AU2002312075A1 (en) Molecules for disease detection and treatment
AU2002249910A1 (en) Molecules for disease detection and treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase